Birth Defects with the Use of Valproate: An  Impact on the Prescribing Pattern amongst  the Health Care Professionals in India

Dr V KALAISELVAN; Dr NISHITH KESERWANI; Dr RISHI KUMAR; Dr RAJEEV SINGH RAGHUVANSHI; Dr KRISHNAMURTHY B

doi:10.59793/ijcp.v35i1.1030

Birth Defects with the Use of Valproate: An Impact on the Prescribing Pattern amongst the Health Care Professionals in India

Authors

Dr V KALAISELVAN Senior Principal Scientific Officer
Dr NISHITH KESERWANI Junior Pharmacovigilance Associate
Dr RISHI KUMAR Ex-Scientific Assistant
Dr RAJEEV SINGH RAGHUVANSHI Secretary-cum-Scientific Director Indian Pharmacopoeia Commission, National Coordination Centre, Pharmacovigilance
Dr KRISHNAMURTHY B Assistant Professor, Dept. of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.59793/ijcp.v35i1.1030

Keywords:

Sodium valproate, valproic acid,, pharmacovigilance,, AMCs,, health care professionals

Abstract

Objective: The present study was carried out to evaluate the impact of Pharmacovigilance Programme of India (PvPI) initiative
to reduce the use of sodium valproate/valproic acid (SV/VA) in the women of childbearing age group. Methods: In our
questionnaire-based study, 251 health care professionals (HCPs) participated from 41 medical colleges across India, which are
also working as Adverse drug reaction Monitoring Centres (AMCs) under PvPI. Results: The data collected at the National
Coordination Centre (NCC) shows the significant decrease in the use of SV/VA in the women of childbearing age group after
the PvPI initiative on Information, Education, and Communication (IEC) materials for HCPs. However, it was found that
40% of HCPs of Gynecology and Neurology Department were still not aware of the initiative taken by the Government of
India to reduce the use of SV/VA in the women of childbearing age group. Conclusion: PvPI, therefore, needs to take more
measures to increase the reach of their resource materials to all HCPs.

Published

2024-06-28

Issue

Vol. 35 No. 1 (2024)

Section

Clinical Study

License

All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that:  The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details.  If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated.  No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.

How to Cite

Birth Defects with the Use of Valproate: An Impact on the Prescribing Pattern amongst the Health Care Professionals in India. (2024). Indian Journal Of Clinical Practice, 35(1), 20-27. https://doi.org/10.59793/ijcp.v35i1.1030